Expression and localization of tenomodulin, a transmembrane type chondromodulin-I-related angiogenesis inhibitor, in mouse eyes

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 5, 2003, Pages 1814-1823

  Oshima, Yusuke ^a,b   Shukunami, Chisa ^b   Honda, Junichi ^b   Nishida, Koji ^a   Tashiro, Fumi ^c   Miyazaki, Jun ichi ^c   Hiraki, Yuji ^b   Tano, Yasuo ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CHONDROMODULIN 1; GLYCOPROTEIN; MESSENGER RNA; TENOMODULIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA; EMBRYOLOGY; ENDOTHELIUM CELL; EXTRAOCULAR MUSCLE; EYE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; IN VITRO STUDY; LENS FIBER; MORPHOGENESIS; MOUSE; NERVE CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RETINA BIPOLAR GANGLION CELL; RETINA GANGLION CELL; SCLERA; SKIN; TENDON; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ADENOVIRIDAE; ANGIOGENESIS INHIBITORS; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CAPILLARIES; CELL DIVISION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; EYE; EYE PROTEINS; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MORPHOGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; TRANSFECTION;

EID: 0242584846     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0664     Document Type: Article

References (51)

1. Adamis AP, Aiello LP, D'Amato RA. Angiogenesis and ophthalmic disease. Angiogenesis. 1999;3:9-14.
2. Aiello LP. Keeping in touch with angiogenesis. Nat Med. 2000;6: 379-381.
3. Folkman J, Klagsberun M. Angiogenic factor. Science. 1987;235: 442-447.
4. Glaser BM. Extracellular modulating factors and the control of intraocular neovascularization. Arch Ophthalmol. 1990;160:603-607.
5. Yoshida A, Yoshida S, Khalil AK, Ishibashi T, Inomata H. Role of NF-kappaB-mediated interleukin-8 expression in intraocular neovascularization. Invest Ophthalmol Vis Sci. 1998;39:1097-1106.
6. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
7. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA. 1995;92:905-909.
8. Ogata N, Tombran-Tink J, Nishikawa M, et al. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment. Am J Ophthalmol. 2001;132:378-382.
9. Schweigerer L, Malerstein B, Neufeld G, Gospodarowicz D. Basic fibroblast growth factor is synthesized in cultured retinal pigment epithelial cells. Biochem Biophys Res Commun. 1987;143:934-940.
10. Sivalingam A, Kenney J, Brown GC, Benson WE, Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol. 1990;108: 869-872.
11. Meyer-Schwickerath R, Pfeiffer A, Blum WF, et al. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease: studies in nondiabetic and diabetic subjects. J Clin Invest. 1993;92:2620-2625.
12. Gerhardinger C, Brown LF, Roy S, Mizutani M, Zucker CL, Lorenzi M. Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. Am J Pathol. 1998;152:1453-1462.
13. Kim I, Ryan AM, Rohan R, et al. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Invest Ophthalmol Vis Sci. 1999;40:2115-2121.
14. Glaser BM, Campochiaro PA, Davis JL Jr, Sato M. Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophthalmol. 1985;103:1870-1875.
15. Brem S, Brem H, Folkman J, Finkelstein D, Patz A. Prolonged tumor dormancy by prevention of neovascularization in the vitreous. Cancer Res. 1976;36:2807-2812.
16. Lutty GA, Thompson DC, Gallup JY, Mello RJ, Patz A, Fenselau A. Vitreous: an inhibitor of retinal extract-induced neovascularization. Invest Ophthalmol Vis Sci. 1983;24:52-56.
17. Jacobson B, Basu PK, Hasany SM. Vascular endothelial cell growth inhibitor of normal and pathologic human vitreous. Arch Ophthalmol. 1984;102:1543-1545.
18. Jacobson B, Dorfman T, Basu PK, Hasany SM. Inhibition of vascular endothelial cell growth and trypsin activity by vitreous. Exp Eye Res. 1985;41:581-595.
19. Lutty GA, Mello RJ, Chandler C, Fait C, Bennett A, Patz A. Regulation of cell growth by vitreous humour. J Cell Sci. 1985;76:53-65.
20. Williams GA, Eisenstein R, Schumacher B, Hsiao KC, Grant D. Inhibitor of vascular endothelial cell growth in the lens. Am J Ophthalmol. 1984;97:366-371.
21. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999; 285:245-248.
22. Duh EJ, Yang HS, Suzuma I, et al. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci. 2002;43:821-829.
23. Ogata N, Wada M, Otsuji T, Jo N, Tombran-Tink J, Matsumura M. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2002;43:1168-1175.
24. Hiraki Y, Tanaka H, Inoue H, Kondo J, Kamizono A, Suzuki F. Molecular cloning of a new class-of cartilage-specific matrix, chon-dromodulin-I, which stimulates growth of cultured chondrocytes. Biochem Biophys Res Commun. 1991;175:971-977.
25. Hiraki Y, Inoue H, Iyama K, et al. Identification of chondromodulin I as a novel endothelial cell growth inhibitor: purification and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem. 1997;272:32419-32426.
26. Hiraki Y, Kono T, Sato M, Shukunami C, Kondo J. Inhibition of DNA synthesis and tube morphogenesis of cultured vascular endothelial cells by chondromodulin-I. FEBS Lett. 1997;415:321-324.
27. Dietz UH, Ziegelmeier G, Bittner K, Bruckner P, Balling R. Spatio-temporal distribution of chondromodulin-I mRNA in the chicken embryo: expression during cartilage development and formation of the heart and eye. Dev Dyn. 1999;216:233-243.
28. Funaki H, Sawaguchi S, Yaoeda K, et al. Expression and localization of angiogenesis inhibitory factor, chondromodulin-I, in adult rat eye. Invest Ophthalmol Vis Sci. 2001;42:1193-1200.
29. Hiraki Y, Mitsui K, Endo N, et al. Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cens. Eur J Biochem. 1999;260:869-878.
30. Hayami T, Shukunami C, Mitsui K, et al. Specific loss of chondromodulin-I gene expression in chondrosarcoma and the suppression of tumor angiogenesis and growth by its recombinant protein in vivo. FEBS Lett. 1999;458:436-440.
31. Yamana K, Wada H, Takahashi Y, Sato H, Kasahara Y, Kiyoki M. Molecular cloning and characterization of CHM1L, a novel membrane molecule similar to chondromodulin-I. Biochem Biophys Res Commun. 2001;280:1101-1106.
32. Shukunami C, Oshima Y, Hiraki Y. Molecular cloning of tenomodulin, a novel chondromodulin-I related gene. Biochem Biophys Res Commun. 2001;280:1323-1327.
33. Brandau O, Meindl A, Fassler R, Aszodi A. A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin-I. Dev Dyn. 2001;221:72-80.
34. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977;36:59-74.
35. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
36. Shukunami C, Iyama K, Inoue H, Hiraki Y. Spatiotemporal pattern of the mouse chondromodulin-I gene expression and its regulatory role in vascular invasion into cartilage during endochondral bone formation. Int J Dev Biol. 1999;43:39-49.
37. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 1991;108:193-199.
38. Tashiro F, Niwa H, Miyazaki J. Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system. Hum Gene Ther. 1999;10:1845-1852.
39. Miyake S, Makimura M, Kanegae Y, et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA. 1996;93:1320-1324.
40. Bishop ET, Bell GT, Bloor S, Broom IJ, Hendry NFK, Wheatley DN. An in vitro model of angiogenesis: basic features. Angiogenesis. 1999;3:335-344.
41. Young B, Heath J. Connective tissues. In: Burkitt H, et al., eds., Wheaters Functional Histology. Edinburgh, Scotland, UK: Churchill Livingstone; 2000;97-192.
42. Goldberg MF. Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am J Ophthalmol. 1997;124:587-626.
43. Miller JW, Adamis AP, Aiello LP. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev. 1997;13:37-50.
44. Snowden JM, Swann DA. Vitreous structure. V. The morphology and thermal stability of vitreous collagen fibers and comparison to articular cartilage (type II) collagen. Invest Ophthalmol Vis Sci. 1980;19:610-618.
45. Liang JN, Chakrabarti B. Spectroscopic studies on pepsin-solubilized vitreous and cartilage collagens. Curr Eye Res. 1981;1:175-181.
46. Poole AR, Pidoux I, Reiner A, Coster L, Hassell JR. Mammalian eyes and associated tissues contain molecules that are immunologically related to cartilage proteoglycan and link protein. J Cell Biol. 1982;93:910-920.
47. Nguyen BQ, Fife RS. Vitreous contains a cartilage-related protein. Exp Eye Res. 1986;43:375-382.
48. Snowden JM, Eyre DR, Swann DA. Vitreous structure. VI. Age- related changes in the thermal stability and crosslinks of vitreous, articular cartilage and tendon collagens. Biochim Biophys Acta. 1982;706:153-157.
49. Heinegard D, Bjorne-Persson A, Coster L, et al. The core proteins of large and small interstitial proteoglycans from various connective tissues form distinct subgroups. Biochem J. 1985;230:181-194.
50. Zhai Y, Ni J, Jiang GW, et al. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J. 1999;13:181-189.
51. Zhai Y, Yu J, Iruela-Arispe L, et al. Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily. Int J Cancer. 1999;82:131-136.